Briefing
ABACUS-2
ESMO 2023 2363MO: neoadjuvant atezolizumab in non-urothelial MIBC. ASCO GU 2026 abstract 832: biomarker analysis of neoadjuvant atezolizumab in UTUC from ABACUS-2. A PubMed-indexed paper and a verified utDNA numeric analysis were not found.